Notable Facts
→Chief Medical Officer at Sangamo Therapeutics, a publicly-traded gene therapy company
→Sangamo Therapeutics focuses on in vivo gene editing for serious diseases
→CMO role indicates senior clinical leadership and regulatory expertise
→Limited public-facing media presence despite executive position
→No widely publicized research publications, awards, or speaking engagements found in public domain